[go: up one dir, main page]

AU2013204721A1 - Methods for treating cachexia - Google Patents

Methods for treating cachexia

Info

Publication number
AU2013204721A1
AU2013204721A1 AU2013204721A AU2013204721A AU2013204721A1 AU 2013204721 A1 AU2013204721 A1 AU 2013204721A1 AU 2013204721 A AU2013204721 A AU 2013204721A AU 2013204721 A AU2013204721 A AU 2013204721A AU 2013204721 A1 AU2013204721 A1 AU 2013204721A1
Authority
AU
Australia
Prior art keywords
methods
treating cachexia
cachexia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013204721A
Other versions
AU2013204721B2 (en
Inventor
Ross Crittendon
Peter Hobman
Paul LEWANDOWSKI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Saputo Dairy Australia Pty Ltd Canada
Original Assignee
Agriculture Victoria Services Pty Ltd
Saputo Dairy Australia Pty Ltd Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009246053A external-priority patent/AU2009246053B2/en
Application filed by Agriculture Victoria Services Pty Ltd, Saputo Dairy Australia Pty Ltd Canada filed Critical Agriculture Victoria Services Pty Ltd
Priority to AU2013204721A priority Critical patent/AU2013204721B2/en
Priority claimed from AU2013204721A external-priority patent/AU2013204721B2/en
Priority to US14/399,845 priority patent/US20150150952A1/en
Priority to PCT/AU2013/000480 priority patent/WO2013166557A1/en
Publication of AU2013204721A1 publication Critical patent/AU2013204721A1/en
Application granted granted Critical
Publication of AU2013204721B2 publication Critical patent/AU2013204721B2/en
Assigned to Saputo Dairy Australia Pty Limited, AGRICULTURE VICTORIA SERVICES PTY LTD reassignment Saputo Dairy Australia Pty Limited Request for Assignment Assignors: AGRICULTURE VICTORIA SERVICES PTY LTD, MURRAY GOULBURN CO-OPERATIVE CO. LIMITED
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013204721A 2008-05-14 2013-04-12 Methods for treating cachexia Ceased AU2013204721B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2013204721A AU2013204721B2 (en) 2008-05-14 2013-04-12 Methods for treating cachexia
US14/399,845 US20150150952A1 (en) 2012-05-10 2013-05-10 Methods for treating cachexia
PCT/AU2013/000480 WO2013166557A1 (en) 2012-05-10 2013-05-10 Methods for treating cachexia

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AU2008902372 2008-05-14
AU2008902365 2008-05-14
AU2009246053A AU2009246053B2 (en) 2008-05-14 2009-05-14 Use of angiogenin or angiogenin agonists for treating diseases and disorders
AU2012901917 2012-05-10
AU2012901917A AU2012901917A0 (en) 2012-05-10 Methods for treating cachexia
AU2013204721A AU2013204721B2 (en) 2008-05-14 2013-04-12 Methods for treating cachexia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2009246053A Division AU2009246053B2 (en) 2008-05-14 2009-05-14 Use of angiogenin or angiogenin agonists for treating diseases and disorders

Publications (2)

Publication Number Publication Date
AU2013204721A1 true AU2013204721A1 (en) 2013-12-12
AU2013204721B2 AU2013204721B2 (en) 2016-08-18

Family

ID=49549995

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013204721A Ceased AU2013204721B2 (en) 2008-05-14 2013-04-12 Methods for treating cachexia

Country Status (3)

Country Link
US (1) US20150150952A1 (en)
AU (1) AU2013204721B2 (en)
WO (1) WO2013166557A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010012437A (en) 2008-05-14 2011-06-01 Agriculture Victoria Serv Pty Use of angiogenin or angiogenin agonists for treating diseases and disorders.
AU2013204740C1 (en) 2012-05-10 2015-10-01 Agriculture Victoria Services Pty Ltd Methods of treating cancer using angiogenin or an angiogenin agonist
US10485502B2 (en) * 2016-12-20 2019-11-26 General Electric Company System and method for assessing muscle function of a patient
CN111329865A (en) * 2020-03-30 2020-06-26 华东理工大学 Application of perphenazine in the preparation of drugs for the treatment of endometrial cancer
WO2022011222A1 (en) * 2020-07-10 2022-01-13 Duke University Compositions and methods for treating cancer-associated cachexia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236977B1 (en) * 1997-11-01 2000-01-15 윤재승 A fusion protein of hegf and human antiogenin, and process for preparing the same
EP1217070A1 (en) * 2000-12-22 2002-06-26 CellGenix Technologie Transfer GmbH Selective cytotoxic fusion proteins
WO2004106491A2 (en) * 2003-05-22 2004-12-09 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Angiogenin-based hiv-1 therapies
BRPI0512394A (en) * 2004-06-22 2008-03-11 Pro Pharmaceuticals Inc compositions and methods for co-distribution of anticancer drugs, antiangiogenic drugs and a polysaccharide
WO2007071051A1 (en) * 2005-12-21 2007-06-28 Viventia Biotech Inc. Novel cancer-associated antigen
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2009039966A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
JP5717625B2 (en) * 2008-05-14 2015-05-13 アグリカルチャー ヴィクトリア サービス ピーティーワイ エルティーディーＡｇｒｉｃｕｌｔｕｒｅ Ｖｉｃｔｏｒｉａ Ｓｅｒｖｉｃｅｓ Ｐｔｙ Ｌｔｄ Angiogenin-enriched milk fraction
MX2010012437A (en) * 2008-05-14 2011-06-01 Agriculture Victoria Serv Pty Use of angiogenin or angiogenin agonists for treating diseases and disorders.
EP2501796A4 (en) * 2009-11-18 2012-12-19 Murray Goulburn Coop Co Ltd Recombinant microorganisms
WO2011060489A1 (en) * 2009-11-18 2011-05-26 Murray Goulburn Co-Operative Co. Limited Transgenic non-human animals
US9855320B2 (en) * 2011-10-06 2018-01-02 Chung-Ang University Industry-Academic Cooperation Foundation Angiogenin for treatment of glaucoma

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating dependence
EP2240140B8 (en) An apparatus for treating gerd
IL212348A0 (en) Treatment method
PT2248083T (en) Method for authentication
WO2010028212A9 (en) Method for cryospray ablation
IL209895A0 (en) Compounds for treating beta-amyloidoses
EP2321009B8 (en) Radiotherapy apparatus
IL208069A0 (en) Methods for treating psoriasis
EP2336384A4 (en) Film-forming method
EP2272472A4 (en) Excrement treating apparatus
EP2351872A4 (en) Treatment method using plasma
WO2011009097A9 (en) Methods for treating schizophrenia
AU2013204721A1 (en) Methods for treating cachexia
WO2010010360A9 (en) Method
EP2296461A4 (en) Methods for treating arthropods
HK1152537A (en) Methods for treating psoriasis
ZA201000867B (en) Methods for treating dependence
AU2008905250A0 (en) Treatment process
AU2007905524A0 (en) A method of treating cachexia
ZA201102198B (en) Treatment method
AU2008903020A0 (en) Treatment
HK1155779A (en) Method
AU2008905455A0 (en) Dermaportation Method
AU2008904040A0 (en) Recarburisation method
AU2008901565A0 (en) Therapeutic method